_id
690f3635ccc777a4e85d1746
Ticker
BLCO
Name
Bausch + Lomb Corp
Exchange
NYSE
Address
520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.bausch.com
Description
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Last Close
16.99
Volume
197124
Current Price
17.09
Change
0.5885815185403263
Last Updated
2025-11-28T12:57:49.383Z
Image
-
Ipo Date
2022-05-06T00:00:00.000Z
Market Cap
5737874944
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9845823529411765
Sentiment Sources
17
Rating
3.5333
Target Price
16.6333
Strong Buy
3
Buy
3
Hold
8
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1281000000
Cost Of Revenue
510000000
Gross Profit
771000000
Operating Expenses
676000000
Operating Income
95000000
Interest Expense
101000000
Pretax Income
-3000000
Net Income
-28000000
Eps
-0.07905138339920949
Dividends Per Share
-
Shares Outstanding
354189784
Income Tax Expense
22000000
EBITDA
207000000
Operating Margin
7.41608118657299
Total Other Income Expense Net
-98000000
Cash
310000000
Short Term Investments
-
Receivables
1094000000
Inventories
1005000000
Total Current Assets
2855000000
Property Plant Equipment
1711000000
Total Assets
13832000000
Payables
395000000
Short Term Debt
28000000
Long Term Debt
4922000000
Total Liabilities
7332000000
Equity
6429000000
Depreciation
109000000
Change In Working Capital
37417170
Cash From Operations
139054302
Capital Expenditures
74521372
Cash From Investing
-61302291
Cash From Financing
-12550256
Net Change In Cash
60000000
PE
-
PB
0.9415582516721107
ROE
-0.43552652045419193
ROA
-0.20242914979757085
FCF
64532930
Fcf Percent
0.05037699453551912
Piotroski FScore
2
Health Score
28
Deep Value Investing Score
5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
3.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1281000000
Quarters > 0 > income Statement > cost Of Revenue
510000000
Quarters > 0 > income Statement > gross Profit
771000000
Quarters > 0 > income Statement > operating Expenses
676000000
Quarters > 0 > income Statement > operating Income
95000000
Quarters > 0 > income Statement > interest Expense
101000000
Quarters > 0 > income Statement > pretax Income
-3000000
Quarters > 0 > income Statement > net Income
-28000000
Quarters > 0 > income Statement > eps
-0.07905138339920949
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
354200000
Quarters > 0 > income Statement > income Tax Expense
22000000
Quarters > 0 > income Statement > EBITDA
207000000
Quarters > 0 > income Statement > operating Margin
7.41608118657299
Quarters > 0 > income Statement > total Other Income Expense Net
-98000000
Quarters > 0 > balance Sheet > cash
310000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1094000000
Quarters > 0 > balance Sheet > inventories
1005000000
Quarters > 0 > balance Sheet > total Current Assets
2855000000
Quarters > 0 > balance Sheet > property Plant Equipment
1711000000
Quarters > 0 > balance Sheet > total Assets
13832000000
Quarters > 0 > balance Sheet > payables
395000000
Quarters > 0 > balance Sheet > short Term Debt
28000000
Quarters > 0 > balance Sheet > long Term Debt
4922000000
Quarters > 0 > balance Sheet > total Liabilities
7332000000
Quarters > 0 > balance Sheet > equity
6429000000
Quarters > 0 > cash Flow > net Income
-28000000
Quarters > 0 > cash Flow > depreciation
109000000
Quarters > 0 > cash Flow > change In Working Capital
37417170
Quarters > 0 > cash Flow > cash From Operations
139054302
Quarters > 0 > cash Flow > capital Expenditures
74521372
Quarters > 0 > cash Flow > cash From Investing
-61302291
Quarters > 0 > cash Flow > cash From Financing
-12550256
Quarters > 0 > cash Flow > net Change In Cash
60000000
Quarters > 0 > ratios > PE
-0.07905138339920949
Quarters > 0 > ratios > PB
0.9415582516721107
Quarters > 0 > ratios > ROE
-0.43552652045419193
Quarters > 0 > ratios > ROA
-0.20242914979757085
Quarters > 0 > ratios > FCF
64532930
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.05037699453551912
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1278000000
Quarters > 1 > income Statement > cost Of Revenue
525000000
Quarters > 1 > income Statement > gross Profit
753000000
Quarters > 1 > income Statement > operating Expenses
764000000
Quarters > 1 > income Statement > operating Income
-11000000
Quarters > 1 > income Statement > interest Expense
128000000
Quarters > 1 > income Statement > pretax Income
-147000000
Quarters > 1 > income Statement > net Income
-62000000
Quarters > 1 > income Statement > eps
-0.1752897936104043
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
353700000
Quarters > 1 > income Statement > income Tax Expense
-89000000
Quarters > 1 > income Statement > EBITDA
88000000
Quarters > 1 > income Statement > operating Margin
-0.8607198748043818
Quarters > 1 > income Statement > total Other Income Expense Net
-136000000
Quarters > 1 > balance Sheet > cash
272000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1088000000
Quarters > 1 > balance Sheet > inventories
1051000000
Quarters > 1 > balance Sheet > total Current Assets
2846000000
Quarters > 1 > balance Sheet > property Plant Equipment
1680000000
Quarters > 1 > balance Sheet > total Assets
13832000000
Quarters > 1 > balance Sheet > payables
449000000
Quarters > 1 > balance Sheet > short Term Debt
28000000
Quarters > 1 > balance Sheet > long Term Debt
4931000000
Quarters > 1 > balance Sheet > total Liabilities
7324000000
Quarters > 1 > balance Sheet > equity
6440000000
Quarters > 1 > cash Flow > net Income
-58000000
Quarters > 1 > cash Flow > depreciation
107000000
Quarters > 1 > cash Flow > change In Working Capital
48000000
Quarters > 1 > cash Flow > cash From Operations
35000000
Quarters > 1 > cash Flow > capital Expenditures
89000000
Quarters > 1 > cash Flow > cash From Investing
-90000000
Quarters > 1 > cash Flow > cash From Financing
90000000
Quarters > 1 > cash Flow > net Change In Cash
57000000
Quarters > 1 > ratios > PE
-0.1752897936104043
Quarters > 1 > ratios > PB
0.9386231366459628
Quarters > 1 > ratios > ROE
-0.9627329192546583
Quarters > 1 > ratios > ROA
-0.44823597455176406
Quarters > 1 > ratios > FCF
-54000000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.04225352112676056
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1137000000
Quarters > 2 > income Statement > cost Of Revenue
482000000
Quarters > 2 > income Statement > gross Profit
655000000
Quarters > 2 > income Statement > operating Expenses
738000000
Quarters > 2 > income Statement > operating Income
-83000000
Quarters > 2 > income Statement > interest Expense
94000000
Quarters > 2 > income Statement > pretax Income
-180000000
Quarters > 2 > income Statement > net Income
-212000000
Quarters > 2 > income Statement > eps
-0.6009070294784581
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
352800000
Quarters > 2 > income Statement > income Tax Expense
31000000
Quarters > 2 > income Statement > EBITDA
20000000
Quarters > 2 > income Statement > operating Margin
-7.299912049252419
Quarters > 2 > income Statement > total Other Income Expense Net
-97000000
Quarters > 2 > balance Sheet > cash
202000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1007000000
Quarters > 2 > balance Sheet > inventories
1031000000
Quarters > 2 > balance Sheet > total Current Assets
2694000000
Quarters > 2 > balance Sheet > property Plant Equipment
1581000000
Quarters > 2 > balance Sheet > total Assets
13428000000
Quarters > 2 > balance Sheet > payables
427000000
Quarters > 2 > balance Sheet > short Term Debt
40000000
Quarters > 2 > balance Sheet > long Term Debt
4789000000
Quarters > 2 > balance Sheet > total Liabilities
6995000000
Quarters > 2 > balance Sheet > equity
6361000000
Quarters > 2 > cash Flow > net Income
-211000000
Quarters > 2 > cash Flow > depreciation
106000000
Quarters > 2 > cash Flow > change In Working Capital
23000000
Quarters > 2 > cash Flow > cash From Operations
-25000000
Quarters > 2 > cash Flow > capital Expenditures
110000000
Quarters > 2 > cash Flow > cash From Investing
-116000000
Quarters > 2 > cash Flow > cash From Financing
31000000
Quarters > 2 > cash Flow > net Change In Cash
-101000000
Quarters > 2 > ratios > PE
-0.6009070294784581
Quarters > 2 > ratios > PB
0.9478622858041188
Quarters > 2 > ratios > ROE
-3.3328093067127815
Quarters > 2 > ratios > ROA
-1.5787905868334822
Quarters > 2 > ratios > FCF
-135000000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.11873350923482849
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1280000000
Quarters > 3 > income Statement > cost Of Revenue
501000000
Quarters > 3 > income Statement > gross Profit
779000000
Quarters > 3 > income Statement > operating Expenses
692000000
Quarters > 3 > income Statement > operating Income
87000000
Quarters > 3 > income Statement > interest Expense
98000000
Quarters > 3 > income Statement > pretax Income
-10000000
Quarters > 3 > income Statement > net Income
-3000000
Quarters > 3 > income Statement > eps
-0.008527572484366117
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
351800000
Quarters > 3 > income Statement > income Tax Expense
-8000000
Quarters > 3 > income Statement > EBITDA
194000000
Quarters > 3 > income Statement > operating Margin
6.796874999999999
Quarters > 3 > income Statement > total Other Income Expense Net
-97000000
Quarters > 3 > balance Sheet > cash
305000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1026000000
Quarters > 3 > balance Sheet > inventories
1036000000
Quarters > 3 > balance Sheet > total Current Assets
2788000000
Quarters > 3 > balance Sheet > property Plant Equipment
1485000000
Quarters > 3 > balance Sheet > total Assets
13469000000
Quarters > 3 > balance Sheet > payables
389000000
Quarters > 3 > balance Sheet > short Term Debt
72000000
Quarters > 3 > balance Sheet > long Term Debt
4744000000
Quarters > 3 > balance Sheet > total Liabilities
6925000000
Quarters > 3 > balance Sheet > equity
6473000000
Quarters > 3 > cash Flow > net Income
-2000000
Quarters > 3 > cash Flow > depreciation
106000000
Quarters > 3 > cash Flow > change In Working Capital
-182000000
Quarters > 3 > cash Flow > cash From Operations
22000000
Quarters > 3 > cash Flow > capital Expenditures
92000000
Quarters > 3 > cash Flow > cash From Investing
-185000000
Quarters > 3 > cash Flow > cash From Financing
146000000
Quarters > 3 > cash Flow > net Change In Cash
-34000000
Quarters > 3 > ratios > PE
-0.008527572484366117
Quarters > 3 > ratios > PB
0.9288215665070292
Quarters > 3 > ratios > ROE
-0.04634636181059787
Quarters > 3 > ratios > ROA
-0.02227336847575915
Quarters > 3 > ratios > FCF
-70000000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.0546875
Quarters > 3 > health Score
25
Valuation > metrics > PE
-0.07905138339920949
Valuation > metrics > PB
0.9415582516721107
Valuation > final Score
70
Valuation > verdict
5.8% Undervalued
Profitability > metrics > ROE
-0.43552652045419193
Profitability > metrics > ROA
-0.9807355516637478
Profitability > metrics > Net Margin
-0.02185792349726776
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1404573028464768
Risk > metrics > Interest Coverage
0.9405940594059405
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.749408983451537
Liquidity > metrics > Quick Ratio
4.373522458628842
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
30
Prev Risks > 1
26
Prev Risks > 2
34
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:27:44.127Z
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year - The Globe and Mail
12/18/2025
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year The Globe and Mail
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$16.6333
Analyst Picks
Strong Buy
3
Buy
3
Hold
8
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 9.02% of the total shares of Bausch + Lomb Corp
1.
ICAHN CARL C(0.9891%)
since
2025/06/30
2.
Deutsche Bank AG(0.9637%)
since
2025/06/30
3.
Alberta Investment Management Corp(0.923%)
since
2025/06/30
4.
D. E. Shaw & Co LP(0.7367%)
since
2025/06/30
5.
Goldentree Asset Management LP(0.73%)
since
2025/06/30
6.
Oaktree Capital Management LLC(0.7125%)
since
2025/06/30
7.
Glenview Capital Management LLC(0.4391%)
since
2025/06/30
8.
Whitebox Advisors, LLC(0.365%)
since
2025/06/30
9.
Nomura Holdings Inc(0.355%)
since
2025/06/30
10.
T. Rowe Price Associates, Inc.(0.353%)
since
2025/06/30
11.
River Road Asset Management, LLC(0.3476%)
since
2025/06/30
12.
Arrowstreet Capital Limited Partnership(0.3141%)
since
2025/06/30
13.
Clearline Capital LP(0.2582%)
since
2025/06/30
14.
Canada Pension Plan Investment Board(0.2407%)
since
2025/06/30
15.
Clark Estates Inc(0.2402%)
since
2025/06/30
16.
UBS Group AG(0.2339%)
since
2025/06/30
17.
Compass Rose Asset Management LP(0.2317%)
since
2025/06/30
18.
FMR Inc(0.2181%)
since
2025/06/30
19.
Allianz Asset Management AG(0.2173%)
since
2025/06/30
20.
TANG CAPITAL MANAGEMENT LLC(0.1554%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.